U.A.E. and Saudi Arabia Men’s Health Market
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2024 –2031 |
 市場規模（基準年） |
USD 334.55 Million |
 Market Size (Forecast Year) |
USD 822.16 Million |
 CAGR |
% |
| Major Markets Players |
|
U.A.E. and Saudi Arabia Men’s Health Market, By Type (Treatment and Diagnosis), Disease Type (Male Erectile Dysfunction, Prostate Cancer, Male Hypogonadism and Male Urinary Incontinence), Age Group (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Home Healthcare and Others) - Industry Trends and Forecast to 2031.
U.A.E. and Saudi Arabia Men’s Health Market Analysis and Size
U.A.E. and Saudi Arabia men’s health market is experiencing significant growth, driven by the rising prevalence of lifestyle diseases, increasing incidence rate of infertility in men, and growing investment in healthcare facilities. The market is driven by several factors, including the rising incidence of lifestyle-related diseases such as diabetes, obesity, and cardiovascular conditions among men in the region. Medical devices play a crucial role in this market, with advancements in prosthetics and implants such as penile prostheses (both inflatable and malleable) designed to treat erectile dysfunction and other urological issues. Diagnostic tools and equipment are also integral, facilitating early detection and treatment of men's health conditions such as prostate cancer and male infertility.
Data Bridge Market Research analyzes that the U.A.E. and Saudi Arabia men’s health market is growing with a CAGR of 12.4% in the forecast period of 2024 to 2031 and is expected to reach USD 822.16 million by 2031 from USD 334.55 million in 2023.
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Year |
2022 (Customizable 2016-2021) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Type (Treatment and Diagnosis), Disease Type (Male Erectile Dysfunction, Prostate Cancer, Male Hypogonadism and Male Urinary Incontinence), Age Group (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Home Healthcare and Others) |
|
Market Players Covered |
Cardinal Health, Pfizer Inc., Astellas Pharma Inc., Novo Nordisk A/S, Lilly, Coloplast Corp., AbbVie Inc., Novartis AG, and Boston Scientic Corporation among others |
Market Definition
U.A.E. and Saudi Arabia men's health market is a comprehensive sector focused on addressing the diverse health needs and concerns of men in these regions. This market encompasses a wide range of products, services, and treatments tailored to men's health issues, including but not limited to reproductive health, urological conditions, cardiovascular diseases, and lifestyle-related disorders. Key components of this market include medical devices, pharmaceuticals, healthcare services, and wellness products.
U.A.E. and Saudi Arabia Men’s Health Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rising Prevalence of Lifestyle Diseases
The rising prevalence of lifestyle diseases such as diabetes, cardiovascular diseases, and obesity significantly drives the men's health market in the U.A.E. and Saudi Arabia by increasing the demand for healthcare services tailored to men's specific health issues. According to the latest figures from SEHA, men in the U.A.E. are not doing enough to take charge of their health. 70% of Emirati men under the age of 30 years are known to suffer from obesity and diabetes. The wellness and fitness industries are thriving as a result, alongside a rapidly expanding pharmaceutical market catering to these conditions. Evolving healthcare infrastructure, with more clinics and advanced technologies, is rising to meet this demand. Consequently, healthcare providers, pharmaceutical companies, and wellness centers are poised for substantial growth, addressing the significant health challenges in these regions.
- Increase Incidence Rate of Infertility in Men
The increasing incidence rate of infertility in men acts as a significant driver in the U.A.E. and Saudi Arabia men's health market by boosting the demand for a wide range of medical services and treatments. A cross-sectional sample of patients seeking fertility treatment in a major fertility clinic in Abu Dhabi, U.A.E. was surveyed from April to May 2021 and result shows that out Of the 42 infertile males, 69.0% had an abnormal semen analysis. As infertility becomes a more prevalent concern, this leads to greater utilization of diagnostic services, including semen analysis, hormonal testing, and genetic evaluations, which necessitates the establishment and expansion of specialized fertility clinics and laboratories. The growing need for effective treatment options, such as medication, surgical interventions, and assisted reproductive technologies such as IVF and ICSI, drives investments in advanced reproductive technologies and specialized healthcare providers.
Opportunity
- Adoption of Telehealth and Digital Solutions
Telehealth and digital solutions are becoming increasingly important in men's health in the U.A.E. and Saudi Arabia. These technologies use advancements in technology to address barriers to access, stigma, and convenience. They enable men to have remote consultations with specialists about sensitive issues such as sexual health and mental well-being from the comfort of their homes. In addition, digital tools allow for continuous monitoring of chronic conditions, personalized wellness plans, and health education, which encourages proactive health management. With supportive regulatory environments and growing acceptance of telemedicine, there is significant potential to enhance healthcare delivery, improve patient outcomes, and promote a culture of preventive care tailored to the specific needs of men in the region.
Restraint/Challenge
- Cultural and Social Barriers
Societal norms and traditional views on masculinity often discourage men from openly discussing health issues, especially those related to mental health and sexual health. The stigma surrounding these topics is expected to lead reluctance in seeking medical help, resulting in untreated or late-diagnosed conditions. This stigma is further compounded by a lack of awareness and education about men's health, both among the general public and within families. Men may feel pressured to conform to cultural expectations of strength and invulnerability, which can prevent them from adopting preventive healthcare measures or seeking timely treatment.
Recent Developments
- In January 2024, Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization
This acquisition complements Cardinal Health's offering in key therapeutic areas by enhancing the company's downstream provider-focused analytics capabilities and service offerings and by accelerating its upstream data and research opportunities with biopharma manufacturers
- In June 2023, Cardinal Health announces the merger of its Outcomes business into Transaction Data Systems and related partnership
The transaction will create a broad, integrated offering of pharmacy workflow software with patient engagement and clinical solutions to serve the patient, pharmacy, payer, and pharmaceutical company ecosystem, including one of the nation's largest networks of 40,000 retail, chain and grocery pharmacies
- In January 2023, Coloplast appoints new President of its global Interventional Urology business. Mentioned, guiding the IU business into the future, where they will reach an increasing number of clients worldwide with both new and current goods and solutions. They are a growth company with a mission, as well as a fantastic place to work
- In January 2018, Lilly announced that it has reached a global settlement in numerous federal lawsuits concerning its testosterone replacement therapy drug Axiron, according to federal court records. This resolution will help the company move forward by mitigating legal uncertainties and allowing it to focus on its core business activities and future innovations
- In November 2023, Boston Scientific recently announced that the U.S. Food and Drug Administration (FDA) has granted approval for its Tenacio pump component, which is a part of the AMS 700 inflatable penile prosthesis (IPP). This approval marks a significant advancement for the AMS 700 IPP, further enhancing its reliability and functionality for patients seeking solutions for erectile dysfunction
U.A.E. and Saudi Arabia Men’s Health Market Scope
U.A.E. and Saudi Arabia men’s health market is segmented into four notable segments based on type, disease type, age group and end user.
Type
- Treatment
- Diagnosis
On the basis of treatment, the U.A.E. and Saudi Arabia men’s health market is segmented into treatment and diagnosis.
Disease type
- Male Erectile Dysfunction
- Prostate Cancer
- Male Hypogonadism
- Male Urinary Incontinence
On the basis of disease type, the U.A.E. and Saudi Arabia men’s health market is segmented into male ercticle dysfunction, prostate cancer, male hypogonadism, male urinary incontience.
Age group
- Geriatric
- Adult
- Pediatric
On the basis of age group, the U.A.E. and Saudi Arabia men’s health market is segmented into geriatric, adult and pediatric.
End user
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others
On the basis of end user, the U.A.E. and Saudi Arabia men’s health market is segmented into hospitals, specialty clinics, home healthcare and others.
U.A.E. and Saudi Arabia Men’s Health Market Regional Analysis/Insights
The U.A.E. and Saudi arabia men’s health market is analyzed and market size insights and trends are provided based on type, disease type, age group and end user as referenced above.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and U.A.E. and Saudi Arabia Men’s Health Market Share Analysis
U.A.E. and Saudi arabia men’s health market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the U.A.E. and Saudi arabia men’s health market.
Some of the major players operating in the U.A.E. and Saudi Arabia men’s health market are Cardinal Health, Pfizer Inc., Astellas Pharma Inc., Novo Nordisk A/S, Lilly, Coloplast Corp., AbbVie Inc., Novartis AG, and Boston Scientic Corporation among others.
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 ENVIRONMENTAL FACTORS
4.1.6 LEGAL FACTORS
4.2 PORTER’S FIVE FORCES
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 BARGAINING POWER OF BUYERS
4.2.4 THREAT OF SUBSTITUTES
4.2.5 COMPETITIVE RIVALRY
5 REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF LIFESTYLE DISEASES
6.1.2 INCREASE INCIDENCE RATE OF INFERTILITY IN MEN
6.1.3 GROWING INVESTMENT FOR HEALTHCARE FACILITIES
6.2 RESTRAINTS
6.2.1 HIGH COST ASSOCIATED WITH THE TREATMENT
6.2.2 SHORTAGE 0F HEALTHCARE WORKERS, PREVENTIVE CARE, AND MENTAL HEALTH SERVICES
6.3 OPPORTUNITIES
6.3.1 ADOPTION OF TELE HEALTH AND DIGITAL SOLUTIONS
6.3.2 TREND IN WELLNESS AND FITNESS AMONG MEN
6.4 CHALLENGES
6.4.1 CULTURAL AND SOCIAL BARRIERS
6.4.2 LACK OF PUBLIC AWARENESS AND EDUCATION
7 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET, BY TYPE
7.1 OVERVIEW
7.2 TREATMENT
7.3 DIAGNOSIS
8 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 MALE ERECTILE DYSFUNCTION
8.3 PROSTATE CANCER
8.4 MALE HYPOGONADISM
8.5 MALE URINARY INCONTINENCE
9 U.A.E. AND SAUDI ARABIA MEN'S HEALTH MARKET, BY AGE GROUP
9.1 OVERVIEW
9.2 GERIATRIC
9.3 ADULT
9.4 PEDIATRIC
10 U.A.E. AND SAUDI ARABIA MEN'S HEALTH MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 SPECIALTY CLINICS
10.4 HOME HEALTHCARE
10.5 OTHERS
11 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: U.A.E.
11.2 COMPANY SHARE ANALYSIS: SAUDI ARABIA
12 SWOT ANALYSIS
13 COMPANY PROFILES
13.1 CARDINAL HEALTH
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 ASTELLAS PHARMA INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT/ SERVICE PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 PFIZER INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 LILLY
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT/ SERVICE PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 COLOPLAST CORP
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 ABBVIE INC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 BOSTON SCIENTIFIC CORPORATION
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 NOVARTIS AG
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT/ SERVICE PORTFOLIO
13.8.4 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS
表のリスト
TABLE 1 U.A.E. MEN'S HEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 2 SAUDI ARABIA MEN'S HEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 3 U.A.E. TREATMENT IN MEN'S HEALTH MARKET, BY BRAND, 2022-2031 (USD MILLION)
TABLE 4 SAUDI ARABIA TREATMENT IN MEN'S HEALTH MARKET, BY BRAND, 2022-2031 (USD MILLION)
TABLE 5 U.A.E. TREATMENT IN MEN'S HEALTH MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 6 SAUDI ARABIA TREATMENT IN MEN'S HEALTH MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
TABLE 7 U.A.E. MEN'S HEALTH MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 8 SAUDI ARABIA MEN'S HEALTH MARKET, BY DISEASE TYPE, 2022-2031 (USD MILLION)
TABLE 9 U.A.E. MEN'S HEALTH MARKET, BY AGE GROUP, 2022-2031
TABLE 10 SAUDI ARABIA MEN'S HEALTH MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)
TABLE 11 U.A.E. MEN'S HEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 12 SAUDI ARABIA MEN'S HEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
図表一覧
FIGURE 1 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: SEGMENTATION
FIGURE 2 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: DATA TRIANGULATION
FIGURE 3 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: DROC ANALYSIS
FIGURE 4 U.A.E. MEN’S HEALTH MARKET: COUNTRIESWISE MARKET ANALYSIS
FIGURE 5 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: COUNTRIESWISE MARKET ANALYSIS
FIGURE 6 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 7 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: MULTIVARIATE MODELLING
FIGURE 8 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: DBMR MARKET POSITION GRID
FIGURE 10 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: MARKET END USER COVERAGE GRID
FIGURE 12 U.A.E. AND SAUDI ARABIA MEN’S HEALTH MARKET: SEGMENTATION
FIGURE 13 RISING PREVALENCE OF LIFESTYLE DISEASES, INCREASE INCIDENCE RATE OF INFERTILITY IN MEN, AND GROWING INVESTMENT FOR HEALTHCARE FACILITIES ARE DRIVING THE SAUDI ARABIA MEN’S HEALTH MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 RISING PREVALENCE OF LIFESTYLE DISEASES, INCREASE INCIDENCE RATE OF INFERTILITY IN MEN, AND GROWING INVESTMENT FOR HEALTHCARE FACILITIES ARE DRIVING THE U.A.E. MEN’S HEALTH MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 TREATMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.A.E. MEN'S HEALTH MARKET IN 2024 TO 2031
FIGURE 16 TREATMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SAUDI ARABIA MEN'S HEALTH MARKET IN 2024 TO 2031
FIGURE 17 PESTEL ANALYSIS
FIGURE 18 PORTER’S FIVE FORCES
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF U.A.E. AND SAUDI ARABIA MEN'S HEALTH MARKET
FIGURE 20 U.A.E. MEN’S HEALTH TYPE MARKET : BY TYPE, 2023
FIGURE 21 U.A.E. MEN’S HEALTH TYPE MARKET : BY TYPE, 2024-2031 (USD MILLION)
FIGURE 22 U.A.E. MEN’S HEALTH TYPE MARKET : BY TYPE, CAGR (2024-2031)
FIGURE 23 U.A.E. MEN’S HEALTH TYPE MARKET : BY TYPE, LIFELINE CURVE
FIGURE 24 SAUDI ARABIA MEN’S HEALTH TYPE MARKET : BY TYPE, 2023
FIGURE 25 SAUDI ARABIA MEN’S HEALTH TYPE MARKET : BY TYPE, 2024-2031 (USD MILLION)
FIGURE 26 SAUDI ARABIA MEN’S HEALTH TYPE MARKET : BY TYPE, CAGR (2024-2031)
FIGURE 27 SAUDI ARABIA MEN’S HEALTH TYPE MARKET : BY TYPE, LIFELINE CURVE
FIGURE 28 U.A.E. MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, 2023
FIGURE 29 U.A.E. MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, 2024-2031 (USD MILLION)
FIGURE 30 U.A.E. MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, CAGR (2024-2031)
FIGURE 31 U.A.E. MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, LIFELINE CURVE
FIGURE 32 SAUDI ARABIA MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, 2023
FIGURE 33 SAUDI ARABIA MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, 2024-2031 (USD MILLION)
FIGURE 34 SAUDI ARABIA MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, CAGR (2024-2031)
FIGURE 35 SAUDI ARABIA MEN’S HEALTH DISEASE TYPE MARKET : BY DISEASE TYPE, LIFELINE CURVE
FIGURE 36 U.A.E. MEN'S HEALTH MARKET: BY AGE GROUP, 2023
FIGURE 37 U.A.E. MEN'S HEALTH MARKET: BY AGE GROUP, 2024-2031 (USD MILLION)
FIGURE 38 U.A.E. MEN'S HEALTH MARKET: BY AGE GROUP, CAGR (2024-2031)
FIGURE 39 U.A.E. MEN'S HEALTH MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 40 SAUDI ARABIA MEN'S HEALTH MARKET: BY AGE GROUP, 2023
FIGURE 41 SAUDI ARABIA MEN'S HEALTH MARKET: BY AGE GROUP, 2024-2031 (USD MILLION)
FIGURE 42 SAUDI ARABIA MEN'S HEALTH MARKET: BY AGE GROUP, CAGR (2024-2031)
FIGURE 43 SAUDI ARABIA MEN'S HEALTH MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 44 U.A.E. MEN'S HEALTH MARKET: BY END USER, 2023
FIGURE 45 U.A.E. MEN'S HEALTH MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 46 U.A.E. MEN'S HEALTH MARKET: BY END USER, CAGR (2024-2031)
FIGURE 47 U.A.E. MEN'S HEALTH MARKET: BY END USER, LIFELINE CURVE
FIGURE 48 SAUDI ARABIA MEN'S HEALTH MARKET: BY END USER, 2023
FIGURE 49 SAUDI ARABIA MEN'S HEALTH MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 50 SAUDI ARABIA MEN'S HEALTH MARKET: BY END USER, CAGR (2024-2031)
FIGURE 51 SAUDI ARABIA MEN'S HEALTH MARKET: BY END USER, LIFELINE CURVE
FIGURE 52 U.A.E. MEN’S HEALTH MARKET: COMPANY SHARE 2023 (%)
FIGURE 53 SAUDI ARABIA MEN’S HEALTH MARKET: COMPANY SHARE 2023 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
